News | September 20, 2023
Jupiter Life Line Hospitals lists at 32.38% premium
The market capitalization of the company stood at Rs. 7,000 crore +
The market capitalization of the company stood at Rs. 7,000 crore +
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The brand has launched 6 new range of products to provide a complete pregnancy care solution
Sets price band at ?695 to ?735 per Equity Share
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Subscribe To Our Newsletter & Stay Updated
